Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergen immunotherapy.

Matthew A Rank1, James T C Li

  • 1Division of Allergic Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Mayo Clinic Proceedings
|September 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms.

The journal of allergy and clinical immunology. Global·2026
Same author

PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.

The Journal of allergy and clinical immunology·2026
Same author

Macrolides for asthma: A systematic review and meta-analysis of randomized trials.

The Journal of allergy and clinical immunology·2026
Same author

A randomized, double-blind, placebo-controlled trial of soluble corn fiber supplementation for children with asthma.

Frontiers in allergy·2026
Same author

In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wk.

Annals of internal medicine·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
Same journal

In Reply: Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study.

Mayo Clinic proceedings·2026
See all related articles

Allergen immunotherapy gradually exposes patients to allergens to reduce allergic responses and symptoms. This established treatment is safe, effective, and being researched for broader applications in allergic diseases.

Area of Science:

  • Immunology
  • Allergy Research

Background:

  • Allergen immunotherapy (AIT) is a treatment for allergic diseases.
  • It involves escalating allergen exposure to induce tolerance.
  • AIT is indicated for allergic rhinoconjunctivitis, asthma, and insect hypersensitivity.

Purpose of the Study:

  • To summarize the current understanding of allergen immunotherapy.
  • To highlight its established efficacy and safety.
  • To discuss emerging research into its mechanisms and potential for wider use.

Main Methods:

  • Review of existing scientific literature and clinical studies.
  • Analysis of established protocols for allergen immunotherapy administration.
  • Examination of recent research on immunological mechanisms.

Related Experiment Videos

Main Results:

  • Allergen immunotherapy demonstrates confirmed safety and efficacy.
  • Treatment involves a build-up phase (weekly injections) followed by a maintenance phase (monthly injections) for 3-5 years.
  • Research is uncovering mechanisms of action, supporting development of improved therapies.

Conclusions:

  • Allergen immunotherapy is a validated treatment for specific allergic conditions.
  • Understanding its mechanisms facilitates the development of safer and more effective therapies.
  • Future research aims to expand AIT applications to a broader spectrum of allergic diseases.